7 December 2017

The appointment went into effect on 1 November 2017. Kramers' teaching and research focuses on medication safety in the hospital setting. Medication errors are one of the biggest risks for hospitalised patients. It is estimated that half of these errors could be prevented through targeted education and supervision of prescribers. The chair therefore has a strong educational orientation.

Kramers is the first Professor of Medication Safety to be appointed in Nijmegen. In the past there has been a long time close collaboration between physicians and pharmacists in Nijmegen. This collaboration is a prerequisite for medication safety.

Kees Kramers (Dirksland, 1962) received his doctorate in Medicine from the University of Leiden in 1986. From 1989 until 1996 he was trained as an internist and from 1996 to 1998 as an internist-clinical pharmacologist, both at Radboud university medical center. In 1995 he obtained his PhD at Radboud University on research into antibodies that play a role in renal failure in the autoimmune disease systemic lupus erythematodes.

Training programmes in medication safety
Since 1989 Kramers has worked at Radboud university medical center on the staff of the Department of Pharmacology-Toxicology, and from 1998 he has also been on the staff of the Department of Internal Medicine, where he is responsible for patient care and teaching and research. Since 2010 he has been seconded to the Clinical Pharmacy Department at Canisius Willhelmina Hospital (CWZ) in Nijmegen. 
In these roles he developed training programmes in medication safety for beginning physician assistants at Radboud university medical center and CWZ. He also chairs the Dutch Society for Clinical Pharmacology & Biopharmacy.

Expertise Centre
His recent achievements include the founding of the Nijmeegs Expertisecentrum voor Complexe Farmacotherapie (‘Nijmegen Expertise Centre for Complex Pharmacotherapy’), a regional partnership between hospital pharmacies, regional general practitioners and public pharmacists, and the development of a compulsory national pharmacotherapy exam for future physicians.

Related news items

1.4 million euro to reduce hospital admissions due to medication

7 January 2022 A team of sixteen Dutch hospitals received a grant of 1.4 million euros from ZonMw. They will investigate whether they can reduce medication related hospital readmissions. read more

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020 With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice. read more

Awardees RIHS Junior Researcher round 2020

23 October 2019 Recently, RIHS held an internal call for Radboudumc junior researcher (PhD) positions. This year 6 positions have been awarded. read more

Three Royal decorations for RIHS researchers

29 April 2019 Peter de Smet, Harry Surayapranata and Stans Verhagen received royal honours for their exceptional academic and social achievements. read more

Beyond the scientist: Kees Kramers

14 December 2017 Appointed Professor of Medication safety on 1 November 2017 within the theme Healthcare improvement science. read more